155 related articles for article (PubMed ID: 20595649)
1. Lead contributes to arterial intimal hyperplasia through nuclear factor erythroid 2-related factor-mediated endothelial interleukin 8 synthesis and subsequent invasion of smooth muscle cells.
Zeller I; Knoflach M; Seubert A; Kreutmayer SB; Stelzmüller ME; Wallnoefer E; Blunder S; Frotschnig S; Messner B; Willeit J; Debbage P; Wick G; Kiechl S; Laufer G; Bernhard D
Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1733-40. PubMed ID: 20595649
[TBL] [Abstract][Full Text] [Related]
2. A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan.
Segev A; Nili N; Osherov AB; Qiang B; Wong AJ; Pillarisetti S; Strauss BH
EuroIntervention; 2010 May; 6(1):134-40. PubMed ID: 20542809
[TBL] [Abstract][Full Text] [Related]
3. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
[TBL] [Abstract][Full Text] [Related]
4. BET Bromodomain Blockade Mitigates Intimal Hyperplasia in Rat Carotid Arteries.
Wang B; Zhang M; Takayama T; Shi X; Roenneburg DA; Kent KC; Guo LW
EBioMedicine; 2015 Nov; 2(11):1650-61. PubMed ID: 26870791
[TBL] [Abstract][Full Text] [Related]
5. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
Ashino T; Yamamoto M; Yoshida T; Numazawa S
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
[TBL] [Abstract][Full Text] [Related]
6. Oral intake of hydrogen-rich water inhibits intimal hyperplasia in arterialized vein grafts in rats.
Sun Q; Kawamura T; Masutani K; Peng X; Sun Q; Stolz DB; Pribis JP; Billiar TR; Sun X; Bermudez CA; Toyoda Y; Nakao A
Cardiovasc Res; 2012 Apr; 94(1):144-53. PubMed ID: 22287575
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of N-cadherin retards smooth muscle cell migration and intimal thickening via induction of apoptosis.
Lyon CA; Koutsouki E; Aguilera CM; Blaschuk OW; George SJ
J Vasc Surg; 2010 Nov; 52(5):1301-9. PubMed ID: 20630685
[TBL] [Abstract][Full Text] [Related]
8. Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein.
Mughal RS; Scragg JL; Lister P; Warburton P; Riches K; O'Regan DJ; Ball SG; Turner NA; Porter KE
Diabetologia; 2010 Aug; 53(8):1761-71. PubMed ID: 20461358
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Mitogen Activated Protein Kinase Activated Protein Kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo.
Muto A; Panitch A; Kim N; Park K; Komalavilas P; Brophy CM; Dardik A
Vascul Pharmacol; 2012; 56(1-2):47-55. PubMed ID: 22024359
[TBL] [Abstract][Full Text] [Related]
10. Endothelial Myocyte Enhancer Factor 2c Inhibits Migration of Smooth Muscle Cells Through Fenestrations in the Internal Elastic Lamina.
Lu YW; Lowery AM; Sun LY; Singer HA; Dai G; Adam AP; Vincent PA; Schwarz JJ
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1380-1390. PubMed ID: 28473437
[TBL] [Abstract][Full Text] [Related]
11. Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by KV1.3 channel blockers.
Cheong A; Li J; Sukumar P; Kumar B; Zeng F; Riches K; Munsch C; Wood IC; Porter KE; Beech DJ
Cardiovasc Res; 2011 Feb; 89(2):282-9. PubMed ID: 20884640
[TBL] [Abstract][Full Text] [Related]
12. Soluble N-cadherin: A novel inhibitor of VSMC proliferation and intimal thickening.
Lyon CA; Wadey KS; George SJ
Vascul Pharmacol; 2016 Mar; 78():53-62. PubMed ID: 26586312
[TBL] [Abstract][Full Text] [Related]
13. Insulin and local growth factor PDGF induce intimal hyperplasia in bypass graft culture models of saphenous vein and internal mammary artery.
Huang B; Dreyer T; Heidt M; Yu JC; Philipp M; Hehrlein FW; Katz N; Al-Fakhri N
Eur J Cardiothorac Surg; 2002 Jun; 21(6):1002-8. PubMed ID: 12048077
[TBL] [Abstract][Full Text] [Related]
14. Blocking potassium channels: a new principle for treating restenosis?
Olschewski A
Cardiovasc Res; 2011 Feb; 89(2):255-7. PubMed ID: 21156820
[No Abstract] [Full Text] [Related]
15. N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway.
Zhao Y; Liu Y; Jing Z; Peng L; Jin P; Lin Y; Zhou Y; Yang L; Ren J; Xie Q; Jin X
Biochem Biophys Res Commun; 2018 Feb; 496(2):415-421. PubMed ID: 29305859
[TBL] [Abstract][Full Text] [Related]
16. Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia.
Osgood MJ; Sexton K; Voskresensky I; Hocking K; Song J; Komalavilas P; Brophy C; Cheung-Flynn J
J Vasc Surg; 2016 Aug; 64(2):471-478. PubMed ID: 27763268
[TBL] [Abstract][Full Text] [Related]
17. Endogenous intermedin protects against intimal hyperplasia by inhibiting endoplasmic reticulum stress.
Xue CD; Chen Y; Ren JL; Zhang LS; Liu X; Yu YR; Tang CS; Qi YF
Peptides; 2019 Nov; 121():170131. PubMed ID: 31408662
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of collagen synthesis, smooth muscle cell proliferation, and injury-induced intimal hyperplasia by halofuginone.
Nagler A; Miao HQ; Aingorn H; Pines M; Genina O; Vlodavsky I
Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):194-202. PubMed ID: 9012656
[TBL] [Abstract][Full Text] [Related]
19. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCα-mediated MKP-1 induction.
Kim SY; Kwon YW; Jung IL; Sung JH; Park SG
Cardiovasc Res; 2011 Nov; 92(2):307-16. PubMed ID: 21840882
[TBL] [Abstract][Full Text] [Related]
20. The effect of resveratrol on intimal hyperplasia and endothelial proliferation of rabbit carotid artery anastomosis.
Karaarslan K; Abud B; Albayrak G; Aykut K; Ergür BU; Silistreli E
Interact Cardiovasc Thorac Surg; 2015 Jan; 20(1):15-20. PubMed ID: 25269652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
